IMM 1.61% 31.5¢ immutep limited

please explain ....., page-3

  1. 160 Posts.
    Long story short. DNDN has a similar treatment for prostate cancer, has been given a the green light for commercialisation by the FDA. Has made a path for PRR to follow in terms of gaining FDA approval.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.